Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China
PaperCitations, authors & open-access status
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 21 citations, 2019 year and closed oa status.
21
Citations
2019
Year
closed
OA Status